Related Articles
Genetically engineered recombinant adenovirus expressing interleukin‑2 for hepatocellular carcinoma therapy
Recombinant adenovirus expressing a dendritic cell‑targeted melanoma surface antigen for tumor‑specific immunotherapy in melanoma mice model
Resveratrol analogue HS-1793 induces the modulation of tumor-derived T cells
Elimination of CD4+ T cells may overcome suppression of anti-HER2 immune responses in tumor-bearing hosts
Kanglaite stimulates anticancer immune responses and inhibits HepG2 cell transplantation‑induced tumor growth